orphan drug

A prescription drug developed to treat diseases affecting fewer than 200,000 people in the United States (such as a rare cancer) or whose developmental costs are not reasonably expected to be recovered from the drug’s sales. 21 USCA § 360bb. [Cases: Health 319.]